Skip to main content
Log in

Extended Abstracts, Allergologie im Kloster, Eltville/Rheingau, 12./13. Mai 2023

Neues zur Anaphylaxie

  • Kongressabstracts
  • Published:
Allergo Journal Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Ring J (ed): Anaphylaxis. Karger Basel 2010

  2. Gupta R, Sheikh A, Strachan DP, Anderson HR: Time trends in allergic disor-ders in the UK. Thorax 2007;62:91-6

  3. Panesar SS, Javad S, de Silva D, Nwaru BI, Hickstein L, Muraro A et al. Sheikh A on behalf of the EAACI Food Allergy and Anaphylaxis Group: The epidemiology of anaphylaxis in Europe: a systematic review. Allergy 2013;68:1353-61

  4. Sousa-Pinto B, Fonseca JA, Gomes ER. Frequency of self-reported drug allergy. A systematic review and metaanalysis with metaregression. Ann Allergy Asthma Immunol 2017;119:362-75

  5. Yang MS, Kim JY, Kim BK, HW Park, SH Cho, KU Min et al. True rise in anaphylaxis incidence: Epidemio-logical study based on a national health insurance database. Medicine (Baltimore) 2017;96:e5750

  6. Lee S, Hess EP, Lohse C, Gilani W, Chamberlain AM, Campbell RL. Trends, characteristics, and incidence of anaphylaxis in 2001-2010: A population-based study. J Allergy Clin Immunol 2017;139:182-8.e2

  7. Parlaman JP, Oron AR, Uspal NG, DeJong KN, Tieder JS. Emergency and hospital care for food-related anaphylaxis in children. Hosp Pediatr 2016;6:269-74

  8. Worm M, Edenharter G, Rueff F, Scherer K, Pföhler C, Mahler V, et al. Symptom profile and risk factors of anaphylaxis in Central Europe. Allergy 2012;67:691-8

  9. Moneret-Vautrin DA, Morisset M, Flabbee J, Beaudouin E, Kanny G. Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy 2005;60:443-551

  10. Ring J, Bachert C, Bauer CP, Czech W (Hrsg.): Weißbuch Allergie in Deutschland. 4. Auflage, Springer, Urban & Vogel GmbH, München, 2018

  11. Panesar SS, Javad S, de Silva D, Nwaru BI, Hickstein L, Muraro A et al. The epidemiology of anaphylaxis in Europe: a systematic review. Allergy 2013;68:1353-61

  12. Grabenheinrich LB, Dölle S, Moneret-Vautrin A, Köhli A, Lange L, Spindler T et al. Anaphylaxis in children and adolescents: The European anaphylaxis registry. J Allergy Clin Immunol 2016;137:1128-37

  13. Genovese A, Rossi FW, Spadaro G, Galdiero MR, Marone G. Human cardiac mast cells in anaphylaxis. Chem Immunol Allergy 2010;95:98-109

  14. Simons FE, Ardusso LR, Bilo MB, El-Gamal YM, Ledford DK, Ring J et al. World Allergy Organization anaphylaxis guidelines: summary. J Allergy Clin Immunol 2011;127:587-93

  15. Worm M, Moneret-Vautrin A, Scherer K, Lang R, Fernandez-Rivas M, Cardona V et al. First European data from the network of severe allergic reactions (NORA). Allergy 2014;69:1397-404

  16. Worm M, Eckermann O, Dölle S, Aberer QW, Beyer K, Hawranek T et al. Triggers and treatment of anaphylaxis: an analysis of 4000 cases from Germany, Austria and Switzerland. Dtsch Ärztebl Int 2014;111:367-75

  17. Ring J, Grosber M, Brockow K. Anaphylaxieerkennung, Notfallbehandlung und Management. Arzneimitteltherapie 2016;34:112-9

  18. Kalesnikoff J, Galli SJ. Anaphylaxis: mechanisms of mast cell activation. Chem Immunol Allergy 2010;95:45-66

  19. Pumphrey R. Anaphylaxis: can we tell who is at risk of a fatal reaction? Curr Opin Allergy Clin Immunol 2004;4:285-90

  20. Pumphrey RSH, Roberts ISD. Postmortem findings after fatal anaphylactic reactions. J Clin Pathol 2000;53:273-6

  21. Hompes S, Dölle S, Grünhagen J, Grabenhenrich L, Worm M. Elicitors and co-factors in food-induced anaphylaxis in adults. Clin Transl Allergy 2013;3:38

  22. Niggemann B, Beyer K. Factors augmenting allergic reactions. Allergy 2014;69:1582-7

  23. Nassiri M, Babina M, Dölle S, Edenharter G, Rueff F, Worm M. Ramipril and metoprolol intake aggravate human and murine anaphylaxis: evidence for di-rect mast cell priming. J Allergy Clin Immunol 2015;135:491-9

  24. Zink A, Ring J, Brockow K. Kofaktorgetriggerte Nahrungsmittelanaphylaxie. Allergologie 2014;37:258-64

  25. Muraro A, Worm M, Alviani C, Cardona V, DunnGalvin A, Garvey LH et al. EAACI guidelines: Anaphylaxis (2021 Update). Allergy 2022;77:357-77

  26. Ring J, Beyer K, Biedermann T, Bircher A, Fischer J, Fuchs T et al. Guideline (S2k) on acute therapy and management of anaphylaxis: 2021 update. Allergo J Int 2021;30:1-25

  27. Deutscher Rat für Wiederbelebung (Hrsg): Reanimatiion 2015 - Leitlinie kompakt 2015: 132-53

  28. Westfall TC, Westfall DP. Adrenergic agonists and antagonists. In: Goodman Gilman's pharmacological basis of therapeutics (Brunton LL, Chab-ner BA, Knollmann BC eds) Mc Graw Hill, New York 2011: pp 272-334

  29. Hoffmann BB. Catecholamines, sympathomimetic drugs and adrenergic recep-tor antagonists. In: Goodman & Gilman: The pharmaceutical basis of therapeutics. Eds: Hardman JG, Limbird LE, Goodman A. Mc Graw Hill, New York 2002

  30. Cotecchia S. The alpha 1 adrenergic receptor: diversity of signaling network and regulation. J Receptor Signal Transduct Res 2010;30:410-9

  31. Santulli G, Iaccarino G. Adrenergic signaling in heart failure and cardiovascular aging. Maturitas 2016;93:65-72

  32. Klimek L, Sperl A, Worm M, Ring J. Notfallset und Akutbehandlung der Anaphylaxie. Das muß der Hausarzt über den allergischen Schock wissen. MMW Fortschr Med 2017;53:74-80

  33. Mostmans Y, Grosber M, Blykers M, Mols P, Naeije N, Gutermuth J. Adrenalin in anaphylaxis treatment and self-administration: experiences from an inner city emergency department. Allergy 2017;72:492-7

  34. Simons FE, Gu X, Simons KJ: Epinephrine absorption in adults: intramuscular versus subcutaneous injection. J Allergy Clin Immunol 2001;108:871-3

  35. Simons FE, Gu X, Simons KJ: Outdated EpiPen and EpiPen Jr auto-injectors: past their prime? J Allergy Clin Immunol 2000;105:1025-30

  36. Srisawat C, Nakponetong K, Benjasupattananun P, Suratannon C, Wachirut-Manggur L, Boonchoo S et al. A preliminary study of intranasal epinephrine administration as a potential route for anaphylaxis treatment. Asian Pac J Allergy Immunol 2016 Mar;34:38-43

  37. Simons FE, Schatz M. Anaphylaxis during pregnancy. J Allergy Clin Immunol 2012;130:597-606

  38. Brown MJ, Brown DC, Murphy MB. Hypokalemia from beta-2-receptor stimu-lation by circulating epinephrine. N Eng J Med 1983;309:1414-9

  39. Brockow K, Beyer K, Biedermann T, Fischer J, Gieler U, Giessler-Fichtner O et al. Supportive care of patients with anaphylaxis - treatment options and short comings: an assessment on behalf of the working group on anaphylaxis training and education (AGATE), Germany. Allergo J Int 2016;25:160-8

  40. European Medicines Agency: Better training tools recommended to support patients using adrenalin auto-injectors. 26 June 2015 EMA/411622/2015

  41. Guerlain S, Hugine A, Wang L. A comparison of 4 epinephrine autoinjector delivery systems: usability and patient preference. Ann Allergy Asthma Immunol 2010;104:172-7

  42. Wölbing F, Biedermann T: Anaphylaxis: opportunities of stratified medicine for diagnosis and risk assessment. Allergy 2013;68:1499-1508

  43. Klimek L. Adrenalin-Autoinjektoren bei Anaphylaxie - als Sprechstundenbedarf verordnungsfähig? Allergo J 2017;26(4):54-55

  44. McNeil C, Copeland J. Accidental digital epinephrine injection: to treat or not to treat? Can Fam Physician 2014;60:726-8

  45. Brockow K, Schallmayer S, Beyer K, Biedermann T, Fischer J, Gebert N et al. Effects of a structured educational intervention on knowledge and emergency management in patients at risk for anaphylaxis. Allergy 2015;70:227-35

  46. Brockow K, Jofer C, Behrendt H, Ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy 2008;a63:226-32

  47. Bresser H, Sander CH, Rakoski J. Insektenstichnotfälle in München. Allergo J 1995;4:373-6

  48. Liyanage CK, Galappatthy P, Seneviratne SL. Corticosteroids in management of anaphylaxis; a systematic review of evidence. Eur Ann Allergy Clin Immuno 2017;49:196-207

  49. Public assessment report- scientific discussion: Emerade® (adrenaline tar-trate). SE/H/ 1261/01-03/II/19;

  50. Study to Explore the Pharmacokinetics and Pharmacodynamics of Epinephrine in Healthy Male and Female Subjects With Different Skin to Muscle Depth (STMD). ClinicalTrials.gov identifier: NCT03282929. Updated June 21, 2019. Accessed October 22, 2020. https://clinicaltrials.gov/ct2/show/NCT03282929.

  51. Worm M, et al. Epinephrine delivery via EPIPEN® Auto-Injector or manual syringe across participants with a wide range of skin-to-muscle distances. Clin Transl Allergy 2020;10:1-13

  52. Fastjekt® Fachinformation Stand Dezember 2022

  53. Emerade® Fachinformation Stand Dezember 2021

  54. Jext® Fachinformation Stand März 2021

  55. Anapen® Fachinformation Stand Januar 2019

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ludger Klimek.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Klimek, L., Blümchen, K. & Ring, J. Extended Abstracts, Allergologie im Kloster, Eltville/Rheingau, 12./13. Mai 2023. Allergo J 32, 47–52 (2023). https://doi.org/10.1007/s15007-023-5716-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15007-023-5716-9

Navigation